OTC Markets Group Welcomes Endo, Inc. to OTCQX
OTC Markets Group has announced that Endo, a specialty pharmaceutical company, has qualified to trade on the OTCQX Best Market. Endo will trade under the symbol 'NDOI' starting today. This listing provides Endo with efficient and cost-effective access to U.S. capital markets, benefiting from streamlined market requirements. Companies trading on OTCQX must meet high financial standards and adhere to best practices in corporate governance. Endo's CEO, Blaise Coleman, noted that this milestone will facilitate easier trading for shareholders and aligns with their strategic priorities to develop and deliver life-enhancing therapies.
- Endo qualifies to trade on the OTCQX Best Market, highlighting its compliance with high financial standards and corporate governance best practices.
- The OTCQX listing provides Endo with cost-effective access to U.S. capital markets, potentially enhancing liquidity and shareholder value.
- None.
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Endo, Inc. (OTCQX: NDOI), a diversified specialty pharmaceutical company, has qualified to trade on the OTCQX® Best Market.
Endo, Inc. begins trading today on OTCQX under the symbol “NDOI.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
Trading on the OTCQX Market offers companies efficient, cost-effective access to the U.S. capital markets. Streamlined market requirements for OTCQX are designed to help companies lower the cost and complexity of being publicly traded, while providing transparent trading for their investors. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws.
“Today’s announcement is an important milestone for Endo. Trading on OTCQX provides trading ease and convenience for shareholders,” said Blaise Coleman, Endo, Inc.’s President and Chief Executive Officer. “We remain focused on creating value for our shareholders as we execute on our strategic priorities through the development and delivery of life-enhancing therapies.”
About Endo, Inc.
Endo is a diversified specialty pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX® Best Market, OTCQB® Venture Market and Pink® Open Market.
Our OTC Link® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets.
OTC Link ATS, OTC Link ECN and OTC Link NQB are each an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.
Subscribe to the OTC Markets RSS Feed
Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, media@otcmarkets.com
FAQ
What is the significance of Endo's trading on OTCQX with the symbol NDOI?
When did Endo begin trading on OTCQX?
How can U.S. investors access Endo's financial disclosures and real-time quotes?
What is the stock symbol for Endo on OTCQX?
